Data Demonstrate Utility Of Fostamatinib For Reducing Mortality, Morbidity In People Hospitalized With COVID-19 Requiring Oxygen

Drug Topics (10/12, Bigica) reports, “Data presented at IDWeek 2023 demonstrates the utility of added fostamatinib to standard of care for reducing mortality and morbidity among people hospitalized with COVID-19 who require oxygen supplementation.” Overal...